The Myc-evoked DNA damage response accounts for treatment resistance in primary lymphomas in vivo

Lowe, 2004, Intrinsic tumour suppression., Nature, 432, 307, 10.1038/nature03098 Zindy, 2003, Arf tumor suppressor promoter monitors latent oncogenic signals in vivo., Proc Natl Acad Sci U S A, 100, 15930, 10.1073/pnas.2536808100 Eischen, 1999, Disruption of the ARF-Mdm2-p53 tumor suppressor pathway in Myc-induced lymphomagenesis., Genes Dev, 13, 2658, 10.1101/gad.13.20.2658 Schmitt, 1999, INK4a/ARF mutations accelerate lymphomagenesis and promote chemoresistance by disabling p53., Genes Dev, 13, 2670, 10.1101/gad.13.20.2670 Braig, 2005, Oncogene-induced senescence as an initial barrier in lymphoma development., Nature, 436, 660, 10.1038/nature03841 Kamijo, 1999, Loss of the ARF tumor suppressor reverses premature replicative arrest but not radiation hypersensitivity arising from disabled atm function., Cancer Res, 59, 2464 Bartkova, 2005, DNA damage response as a candidate anti-cancer barrier in early human tumorigenesis., Nature, 434, 864, 10.1038/nature03482 Gorgoulis, 2005, Activation of the DNA damage checkpoint and genomic instability in human precancerous lesions., Nature, 434, 907, 10.1038/nature03485 Bartkova, 2006, Oncogene-induced senescence is part of the tumorigenesis barrier imposed by DNA damage checkpoints., Nature, 444, 633, 10.1038/nature05268 Mallette, 2007, The DNA damage signaling pathway is a critical mediator of oncogene-induced senescence., Genes Dev, 21, 43, 10.1101/gad.1487307 Lee, 1999, Ras proteins induce senescence by altering the intracellular levels of reactive oxygen species., J Biol Chem, 274, 7936, 10.1074/jbc.274.12.7936 Vafa, 2002, c-Myc can induce DNA damage, increase reactive oxygen species, and mitigate p53 function: a mechanism for oncogene-induced genetic instability., Mol Cell, 9, 1031, 10.1016/S1097-2765(02)00520-8 Tanaka, 2002, Deregulated G1-cyclin expression induces genomic instability by preventing efficient pre-RC formation., Genes Dev, 16, 2639, 10.1101/gad.1011002 Di Micco, 2006, Oncogene-induced senescence is a DNA damage response triggered by DNA hyper-replication., Nature, 444, 638, 10.1038/nature05327 Savitsky, 1995, A single ataxia telangiectasia gene with a product similar to PI-3 kinase., Science, 268, 1749, 10.1126/science.7792600 Varon, 1998, Nibrin, a novel DNA double-strand break repair protein, is mutated in Nijmegen breakage syndrome., Cell, 93, 467, 10.1016/S0092-8674(00)81174-5 Malkin, 1990, Germ line p53 mutations in a familial syndrome of breast cancer, sarcomas, and other neoplasms., Science, 250, 1233, 10.1126/science.1978757 Bell, 1999, Heterozygous germ line hCHK2 mutations in Li-Fraumeni syndrome., Science, 286, 2528, 10.1126/science.286.5449.2528 Chang, 1987, Oncogenes in radioresistant, noncancerous skin fibroblasts from a cancer-prone family., Science, 237, 1036, 10.1126/science.3616624 Shiloh, 2003, ATM and related protein kinases: safeguarding genome integrity., Nat Rev Cancer, 3, 155, 10.1038/nrc1011 Bakkenist, 2003, DNA damage activates ATM through intermolecular autophosphorylation and dimer dissociation., Nature, 421, 499, 10.1038/nature01368 Pellegrini, 2006, Autophosphorylation at serine 1987 is dispensable for murine Atm activation in vivo., Nature, 443, 222, 10.1038/nature05112 Ali, 2004, Requirement of protein phosphatase 5 in DNA-damage-induced ATM activation., Genes Dev, 18, 249, 10.1101/gad.1176004 Lindstrom, 2003, Myc and E2F1 induce p53 through p14ARF-independent mechanisms in human fibroblasts., Oncogene, 22, 4993, 10.1038/sj.onc.1206659 Li, 2004, ATM activity contributes to the tumor-suppressing functions of p14ARF., Oncogene, 23, 7355, 10.1038/sj.onc.1207957 Xu, 1996, Dual roles of ATM in the cellular response to radiation and in cell growth control., Genes Dev, 10, 2401, 10.1101/gad.10.19.2401 Westphal, 1997, atm and p53 cooperate in apoptosis and suppression of tumorigenesis, but not in resistance to acute radiation toxicity., Nat Genet, 16, 397, 10.1038/ng0897-397 Cuneo, 2000, Acquired chromosome 11q deletion involving the ataxia teleangiectasia locus in B-cell non-Hodgkin's lymphoma: correlation with clinicobiologic features., J Clin Oncol, 18, 2607, 10.1200/JCO.2000.18.13.2607 Haidar, 2000, ATM gene deletion in patients with adult acute lymphoblastic leukemia., Cancer, 88, 1057, 10.1002/(SICI)1097-0142(20000301)88:5<1057::AID-CNCR16>3.0.CO;2-6 Korz, 2002, Evidence for distinct pathomechanisms in B-cell chronic lymphocytic leukemia and mantle cell lymphoma by quantitative expression analysis of cell cycle and apoptosis-associated genes., Blood, 99, 4554, 10.1182/blood.V99.12.4554 Liyanage, 2000, Abnormal rearrangement within the alpha/delta T-cell receptor locus in lymphomas from Atm-deficient mice., Blood, 96, 1940, 10.1182/blood.V96.5.1940 Pusapati, 2006, ATM promotes apoptosis and suppresses tumorigenesis in response to Myc., Proc Natl Acad Sci U S A, 103, 1446, 10.1073/pnas.0507367103 Shreeram, 2006, Regulation of ATM/p53-dependent suppression of myc-induced lymphomas by Wip1 phosphatase., J Exp Med, 203, 2793, 10.1084/jem.20061563 Adams, 1985, The c-myc oncogene driven by immunoglobulin enhancers induces lymphoid malignancy in transgenic mice., Nature, 318, 533, 10.1038/318533a0 Barlow, 1996, Atm-deficient mice: a paradigm of ataxia telangiectasia., Cell, 86, 159, 10.1016/S0092-8674(00)80086-0 Jacks, 1992, Effects of an Rb mutation in the mouse., Nature, 359, 295, 10.1038/359295a0 Kamijo, 1997, Tumor suppression at the mouse INK4a locus mediated by the alternative reading frame product p19ARF., Cell, 91, 649, 10.1016/S0092-8674(00)80452-3 Dumon-Jones, 2003, Nbn heterozygosity renders mice susceptible to tumor formation and ionizing radiation-induced tumorigenesis., Cancer Res, 63, 7263 Schmitt, 2002, A senescence program controlled by p53 and p16INK4a contributes to the outcome of cancer therapy., Cell, 109, 335, 10.1016/S0092-8674(02)00734-1 Hartley, 1999, Measurement of DNA cross-linking in patients on ifosfamide therapy using the single cell gel electrophoresis (comet) assay., Clin Cancer Res, 5, 507 Ehlich, 1994, Analysis of the B-cell progenitor compartment at the level of single cells., Curr Biol, 4, 573, 10.1016/S0960-9822(00)00129-9 Kamijo, 1998, Functional and physical interactions of the ARF tumor suppressor with p53 and Mdm2., Proc Natl Acad Sci U S A, 95, 8292, 10.1073/pnas.95.14.8292 Zindy, 1998, Myc signaling via the ARF tumor suppressor regulates p53-dependent apoptosis and immortalization., Genes Dev, 12, 2424, 10.1101/gad.12.15.2424 Bertwistle, 2007, Regulation of the Arf tumor suppressor in Emicro-Myc transgenic mice: longitudinal study of Myc-induced lymphomagenesis., Blood, 109, 792, 10.1182/blood-2006-07-033985 Schmitt, 2002, Dissecting p53 tumor suppressor functions in vivo., Cancer Cell, 1, 289, 10.1016/S1535-6108(02)00047-8 Smith, 2006, MYC levels govern hematopoietic tumor type and latency in transgenic mice., Blood, 108, 653, 10.1182/blood-2006-01-0172 Falck, 2001, The ATM-Chk2-Cdc25A checkpoint pathway guards against radioresistant DNA synthesis., Nature, 410, 842, 10.1038/35071124 Burma, 2001, ATM phosphorylates histone H2AX in response to DNA double-strand breaks., J Biol Chem, 276, 42462, 10.1074/jbc.C100466200 Ward, 2001, Histone H2AX is phosphorylated in an ATR-dependent manner in response to replicational stress., J Biol Chem, 276, 47759, 10.1074/jbc.C100569200 Sagun, 2006, Antioxidants prevent oxidative DNA damage and cellular transformation elicited by the over-expression of c-MYC., Mutat Res, 593, 64, 10.1016/j.mrfmmm.2005.06.015 Bartkova, 2005, ATM activation in normal human tissues and testicular cancer., Cell Cycle, 4, 838, 10.4161/cc.4.6.1742 Xu, 1998, Involvement of p53 and p21 in cellular defects and tumorigenesis in Atm-/- mice., Mol Cell Biol, 18, 4385, 10.1128/MCB.18.7.4385 Schmitt, 2000, DNA damage responses and chemosensitivity in the Eμ-myc mouse lymphoma model., Cold Spring Harb Symp Quant Biol, 65, 499, 10.1101/sqb.2000.65.499 Braig, 2006, Oncogene-induced senescence: putting the brakes on tumor development., Cancer Res, 66, 2881, 10.1158/0008-5472.CAN-05-4006 Serrano, 1997, Oncogenic ras provokes premature cell senescence associated with accumulation of p53 and p16INK4a., Cell, 88, 593, 10.1016/S0092-8674(00)81902-9 Brown, 2003, Essential and dispensable roles of ATR in cell cycle arrest and genome maintenance., Genes Dev, 17, 615, 10.1101/gad.1067403 Stiff, 2005, Nbs1 is required for ATR-dependent phosphorylation events., EMBO J, 24, 199, 10.1038/sj.emboj.7600504 Ray, 2006, MYC can induce DNA breaks in vivo and in vitro independent of reactive oxygen species., Cancer Res, 66, 6598, 10.1158/0008-5472.CAN-05-3115 Aslanian, 2004, Repression of the Arf tumor suppressor by E2F3 is required for normal cell cycle kinetics., Genes Dev, 18, 1413, 10.1101/gad.1196704 Efeyan, 2006, Tumour biology: policing of oncogene activity by p53., Nature, 443, 159, 10.1038/443159a Gronbaek, 2002, ATM mutations are associated with inactivation of the ARF-TP53 tumor suppressor pathway in diffuse large B-cell lymphoma., Blood, 100, 1430, 10.1182/blood-2002-02-0382 Tort, 2002, CHK2-decreased protein expression and infrequent genetic alterations mainly occur in aggressive types of non-Hodgkin lymphomas., Blood, 100, 4602, 10.1182/blood-2002-04-1078 Trachootham, 2006, Selective killing of oncogenically transformed cells through a ROS-mediated mechanism by beta-phenylethyl isothiocyanate., Cancer Cell, 10, 241, 10.1016/j.ccr.2006.08.009 Kurz, 2004, Doxorubicin activates ATM-dependent phosphorylation of multiple downstream targets in part through the generation of reactive oxygen species., J Biol Chem, 279, 53272, 10.1074/jbc.M406879200